Why biotech investors need a research ombudsman
A seed fund and dual university study of digital health start-ups has found that many companies had a clinical robustness score of zero.
Source: afr.com
Stay updated with breaking news from Eudaemon Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A seed fund and dual university study of digital health start-ups has found that many companies had a clinical robustness score of zero.